Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets
... forecast trends and sales through 2024. Important manufacturers, technologies and factors influencing demand are discussed. The market has been segregated geographically into the U.S., Japan and five major European markets (Germany, France, Italy, Spain, and ... Read More
-
Pulmonary Arterial Hypertension - Pipeline Review, H2 2020
... Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms ... Read More
-
Cystic Fibrosis (CF) – Pipeline Insight, 2020
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Cystic ... Read More
-
Respiratory Diseases Drugs Investment Global Outlook 2020
... the economic slowdown across countries owing to the pandemic outbreak. The market is then expected to recover and grow at a CAGR of 4.38% from 2020 to reach $73.86 billion in 2023. Respiratory Diseases Drugs ... Read More
-
Global Artificial Heart Lung Machines Market Growth 2020-2025
... market size will reach $ 288.5 million by 2025, from $ 257.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Heart Lung Machines ... Read More
-
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029
... or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, ... Read More
-
Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029
... et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing ... Read More
-
Global Human Respiratory Syncytial Virus Drugs Market Research Report 2020-2024
... Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) ... Read More
-
Respiratory Inhalers Market - Global Outlook and Forecast 2020-2025
... expected to grow at a CAGR of over 9% during the period 2019–2025. The global respiratory inhalers market is one of the steadily growing segments in the medical devices market. The steady growth can be ... Read More
-
Acute respiratory distress syndrome (ARDS) – Pipeline Insight, 2020
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Non-cystic Fibrosis Bronchiectasis (NCFB) – Pipeline Insight, 2020
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global ... Read More
-
Pneumonia Treatment Drugs Markets in China
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More
-
Global Respiratory Partnering 2010-2020: Deal trends, players and financials
... in Respiratory partnering deals Financial deal terms for headline, upfront and royalty by stage of development Respiratory partnering agreement structure Respiratory partnering contract documents Top Respiratory deals by value Most active Respiratory dealmakers Most of ... Read More
-
Pneumonia Treatment Drugs Companies in China
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More
-
Lung Cancer Diagnostics
... and medical expenditure. Rising environmental pollution is taking its toll on the health of the population. Among the many factors attributed to the epidemic spread of cancer is the rising air pollution as evidenced by ... Read More
-
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2020
... trials scenario. This report provides top line data relating to the clinical trials on Acute Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
2024 UK Respiratory Disease Testing Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
... UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and ... Read More
-
Pulmonary Embolism - Pipeline Review, H2 2020
... landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood clot. Symptoms include shortness of breath, chest pain, cough, leg pain or swelling, excessive sweating, ... Read More
-
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2020
... of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and ... Read More
-
2024 Italy Respiratory Disease Testing Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
... Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and ... Read More
-
2024 USA Respiratory Disease Testing Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
... US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and ... Read More
-
Cough - Pipeline Review, H2 2020
... a reflex action that clears the throat of mucus or foreign irritants. Signs and symptoms include stuffy nose, hoarseness, wheezing and shortness of breath and heartburn or a sour taste in mouth. Risk factors include ... Read More
-
2024 France Respiratory Disease Testing Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
... French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and ... Read More
-
2024 Germany Respiratory Disease Testing Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
... German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and ... Read More
-
RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)); Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Diso
... Diseases, and Other); Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others); End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals), and Geography The RNAi therapeutics market was valued at ... Read More
